XXE5XV7 Measurement of Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection, New Technology Group 7

• Section: New Technology
• Body system: Physiological Systems
• Operation: Measurement — Determining the level of a physiological or physical function at a point in time

How XXE5XV7 is built

1. Section: X New Technology
2. Body system: X Physiological Systems
3. Root operation: E Measurement
4. Body part: 5 Circulatory
5. Approach: X External
6. Device: V Infection, Serum/Plasma Nanoparticle Fluorescence SARS-CoV-2 Antibody Detection
7. Qualifier: 7 New Technology Group 7

ICD-10-PCS Official Guidelines on Measurement

All section E guidelines

Code history

added FY2022.

Other XXE codes for the same body part

• XXE5X2A Measurement of Infection, Phenotypic Fully Automated Rapid Susceptibility Technology with Controlled Inoculum, New Technology Group 10
• XXE5X38 Measurement of Infection, Whole Blood Reverse Transcription and Quantitative Real-time Polymerase Chain Reaction, New Technology Group 8
• XXE5X4A Measurement of Infection, Positive Blood Culture Small Molecule Sensor Array Technology, New Technology Group 10
• XXE5X5A Measurement of Immune Response, Whole Blood Cellular Assessment via Microfluidic Deformability, New Technology Group 10
• XXE5XBB Measurement of Infection and Immune Response, Gene Expression Testing System, New Technology Group 11
• XXE5XY9 Measurement of Infection, Other Positive Blood/Isolated Colonies Bimodal Phenotypic Susceptibility Technology, New Technology Group 9